Dec 14, 2010

Indofarma eyes Rp1.1 trillion sales

The state-owned pharmaceutical maker PT Indofarma Tbk (INAF) estimates Rp1.1 trillion sales by end of this year.
In a presentation material published to Indonesia Stock Exchange (IDX), Indofarma posted Rp850 billion sales by end of November 2010.
Indofarma is expected to reach Rp47 billion operating profit and Rp10.64 billion net profit.
The company plans to spend Rp59 billion capital expenditure in 2011. About 15% of the expenditure will be fulfilled by internally generated cash flow.

Disclosure: No position at the stock mentioned above.
 
Print This Article

No comments: